Solgar Beta 1,3 Glucans 60 Tablets
Solgar Beta 1,3 Glucans 60 Tablets
What 500,000+ customers say about medino:
Description
Solgar Beta 1,3 Glucans 60 Tablets is a food supplement that provides 200 mg of beta glucans per tablet, as Beta 1-3 and Beta 1-6 glucans from yeast cell wall concentrate. Beta glucans are a type of soluble fibre found in the cell walls of yeast and fungi. The tablets are suitable for vegans and vegetarians, and the daily amount is flexible, from 1 to 3 tablets.
Key Features
- 200 mg beta glucans per tablet: Each tablet contains 200 mg of beta glucans, as Beta 1-3 and Beta 1-6 glucans.
- Yeast cell wall source: The beta glucans come from concentrated yeast cell wall material.
- Vegan, vegetarian and gluten free: Solgar lists the tablets as suitable for vegans and vegetarians, and as gluten free.
- Flexible daily amount: The directions allow 1 to 3 tablets a day, so you can choose the amount within that range.
What are beta glucans?
Beta glucans are a type of soluble fibre, sometimes described as naturally occurring sugars. They form part of the structure of cell walls in foods containing yeast and fungi. In this product they come from concentrated yeast cell wall material.
How long does a 60-tablet bottle last?
A bottle of 60 tablets lasts 60 days at 1 tablet a day, or 20 days at 3 tablets a day.
Can I use it instead of a varied diet?
No. Food supplements should not be used instead of a varied, balanced diet and a healthy lifestyle.
Ingredients
Active ingredient: Beta glucans 200 mg per tablet (as Beta 1-3 and Beta 1-6 glucans, from yeast cell wall concentrate).
Other ingredients: Bulking agent: microcrystalline cellulose. Anti-caking agents: vegetable stearic acid, silicon dioxide, vegetable magnesium stearate. Cross-linked cellulose gum. Glazing agents: hydroxypropylmethyl cellulose, vegetable glycerin (from palm kernel oil and coconut oil).
Usage and Instructions
Take 1 to 3 tablets daily.
Warnings
Food supplements should not be used instead of a varied, balanced diet and a healthy lifestyle.